Codexis (CDXS) Invested Capital (2019 - 2020)
Codexis' (CDXS) quarterly Invested Capital came in at $9000.0 in Q1 2020, down 96.28% year-on-year from $242000.0 in Q2 2019, and down 85.0% quarter-over-quarter from $60000.0 in Q4 2019.
Codexis (CDXS) Invested Capital (2019 - 2020) Analysis & Trends
Codexis' Invested Capital history runs 2 years deep, the most recent figure standing at $9000.0 for Q1 2020.
- On a quarterly basis, Invested Capital fell 96.28% year-over-year to $9000.0 in Q1 2020; TTM through Dec 2020 was $9000.0, a 98.52% decrease from a year earlier, with the FY2019 full-year figure at $60000.0, changed N/A from the prior year.
- Invested Capital fell to $9000.0 in Q1 2020 per CDXS's latest filing, from $60000.0 in the prior quarter.
- Across five years, Invested Capital topped out at $242000.0 in Q1 2019 and bottomed at $9000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 116.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Codexis | 180.63 Mn | 115.49 Mn | 13.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 9,000.00 |
| Dec 31, 2019 | 60,000.00 |
| Sep 30, 2019 | 122,000.00 |
| Jun 30, 2019 | 183,000.00 |
| Mar 31, 2019 | 242,000.00 |